Novel brain-on-chip model to revolutionize drug development for neurological disorders
| Title | Novel brain-on-chip model to revolutionize drug development for neurological disorders |
|---|---|
| Acronym | NEUROCHIP |
| Start date | 2021-10-01 |
| End date | 2024-09-30 |
| Sponsor | Gustave Roussy |
| Institution | NMI Natural and Medical Sciences Institute at the University of Tübingen |
Associated cell lines
Project Description
We will deliver a validated and tested version of NEUROCHIP, a ground-breaking brain-on-chip (BoC) system that allows culturing, imaging, and recording of brain organoids from any source. NEUROCHIP offers revolutionary translational power as the world’s first solution that enables robust assessment of neuronal activity in human-derived 3D brain organoids, empowering research and drug development for a wide range of neurological diseases.